vôtre suivi ce jour merci

Entrée	Pages vues
France	381
Italie	182
États-Unis	25
Allemagne	9
Pologne	9
Ukraine	5
Algérie	4
Portugal	4
Irlande	2
Islande	2

merci pour vôtre suivi

Pages vues aujourd'hui

59

Pages vues hier

107

Pages vues le mois dernier

3 669

Historique global des pages vues

243 216

Clovis Oncology Announces Presentations at 2018 ASCO Annual Meeting | Business Wire

Clovis Oncology Announces Presentations at 2018 ASCO Annual Meeting | Business Wire: Clovis Oncology, Inc. (NASDAQ: CLVS) today announced that seven abstracts highlighting progress in the Rubraca preclinical research and clinical devel

PharmaCyte Biotech Successfully Completes 29 Tests Conducted on Live Cells Used in Pancreatic Cancer Therapy | Business Wire

PharmaCyte Biotech Successfully Completes 29 Tests Conducted on Live Cells Used in Pancreatic Cancer Therapy | Business Wire: PharmaCyte Biotech announces successful completion of 29 tests conducted on live cells used in pancreatic cancer therapy.

Myonexus Therapeutics Receives FDA Rare Pediatric Drug Designation for Pioneering Treatment of Limb Girdle Muscular Dystrophy Type 2E | Business Wire

Myonexus Therapeutics Receives FDA Rare Pediatric Drug Designation for Pioneering Treatment of Limb Girdle Muscular Dystrophy Type 2E | Business Wire: Myonexus Therapeutics receives FDA Rare Pediatric Drug Designation for pioneering gene therapy treatment of limb girdle muscular dystrophy type 2E.

Scientist.com and Brain and Spine Institute’s Bioincubator, iPEPS, Launch Biotech Startup Competition for Companies Accelerating CNS Disease Research | Business Wire

Scientist.com and Brain and Spine Institute’s Bioincubator, iPEPS, Launch Biotech Startup Competition for Companies Accelerating CNS Disease Research | Business Wire: Scientist.com, the life science industry’s leading online marketplace for outsourced research, and The Brain and Spine Institute incubator, iPEPS-ICM,

Kommuniké från årsstämman i LIDDS

Kommuniké från årsstämman i LIDDS